Catalyst Wire Dossier Catalyst Wire Dossier

T10430 Eye Drops

· Laboratoires Thea
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for T10430 Eye Drops, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of T10430 Eye Drops in Controlling Paediatric Myopia Progression [Phase 2]

See pricing